Cannabis Bioscience International Holdings Inc
cbih.netWhat Do They Do?
Conducts clinical trials for sponsors and clinical research organizations, and provides cannabis-related education for workers in the cannabis industry.
10-K for FY2025, filed Sep 22, 2025The Company conducts clinical trials, some of which may involve cannabis and CBD products as a Sponsor and a CRO under the trade name Alpha…View ↗
Through the Pharmacology University Business, the Company provides knowledge and promotes professionalism in the rapidly growing cannabis…View ↗
Pharmacology University’s business and prospects are influenced by the growth of the cannabis industry and by the demand for experienced…View ↗
How Do They Make Money?
Sponsors and clinical research organizations pay for clinical-trial services through progress payments tied to patients seen, with final payment due when the work is completed or the contract ends. Consulting and educational customers pay in advance; merchandise sales are paid when goods ship.
10-K for FY2025, filed Sep 22, 2025The Company conducts clinical trials, some of which may involve cannabis and CBD products as a Sponsor and a CRO under the trade name Alpha…View ↗
Our significant payment terms for customer contracts vary based on the revenue stream. Contracts for clinical trials typically provide for…View ↗
Contracts for educational services require non-refundable payment in advance and are recorded as revenue when received.View ↗
The Company generates revenue from multiple streams, namely, clinical trials, consulting fees, seminars and merchandise sales. Revenues…View ↗
-
10-K for FY2025, filed Sep 22, 2025
FY2025 revenue by product or service ↗
$303K
-
10-K for FY2025, filed Sep 22, 2025
$303K ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Clinical Trials
Sold outright
10-K for FY2025, filed Sep 22, 2025 |
100% |
Clinical Trials, FY2025
$301.7K Sources
|
Sold outright |
|
Consulting Fees
Sold outright
|
0.0% |
Consulting Fees, FY2025
$0 Sources
|
Sold outright |
|
Seminar Fees
Sold outright
|
0.0% |
Seminar Fees, FY2025
$0 Sources
|
Sold outright |
|
Merchandise
Sold outright
|
0.4% |
Merchandise, FY2025
$1.3K Sources
|
Sold outright |
Who Are Their Customers?
Sponsors and clinical research organizations contract for clinical-trial work; cannabis-industry workers and leaders are the audience for Pharmacology University's classes, seminars and online education.
10-K for FY2025, filed Sep 22, 2025The Company conducts clinical trials, some of which may involve cannabis and CBD products as a Sponsor and a CRO under the trade name Alpha…View ↗
Through the Pharmacology University Business, the Company provides knowledge and promotes professionalism in the rapidly growing cannabis…View ↗
Pharmacology University’s business and prospects are influenced by the growth of the cannabis industry and by the demand for experienced…View ↗
Our significant payment terms for customer contracts vary based on the revenue stream. Contracts for clinical trials typically provide for…View ↗
10-K for FY2025, filed Sep 22, 2025
The Company has depended on a few customers of Alpha Research Business for substantial portions of its revenue. For the year ended May 31…View ↗
Do Revenues Turn Into Profits?
No. It lost $548.8K in FY2025.
10-K for FY2025, filed Sep 22, 2025
How Are They Changing?
- Net income
-
Sources
10-Q for Q3 FY2026, filed Apr 16, 2026
−$103.9KView ↗
- ▼ −43% (Loss)
- vs −$181.2K in Q3 FY2025
10-Q for Q3 FY2026, filed Apr 16, 2026
Open tableView ↗
Loading...
